Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Operating Margins |
24.01% |
| Profit Margins |
11.78% |
| Return on Equity |
13.49% |
| Return on Assets |
5.7% |
| Free Float |
0.21B |
| Dividend Yield |
0.37% |
| Short Int % Utilisation |
4.38% |
2.2 Growth
| Metric |
Value |
| Revenue Growth |
11.9% |
| Free Cash Flow |
2.22B |
| EBITDA |
33.55 (Ratio) |
| Enterprise Value |
49.83B |
| EV/Revenue |
6.62 |
| EV/EBITDA |
33.55 |
Revenue growth of 11.9% indicates steady, moderate expansion.
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
24.06% |
| Risk / Std Dev (Ann.)* |
18.15% |
| 1-Year Price Return* |
20.53% |
Latest Market Data (as of 2026-08-04, US Eastern time):
| Metric |
Value |
| Last Price |
$209.70 |
| 52-Week Range |
$164.50 – $210.20 |
| Observation Count |
236 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
DuPont Model Analysis
The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:
ROE = Net Margin × Asset Turnover × Equity Multiplier
The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.
| DuPont component |
Calculation |
FY2026 |
FY2025 |
| Revenue |
Reported revenue |
$7.53B |
$7.46B |
| Net income |
Reported net income |
$887.00M |
$1.12B |
| Total assets |
Year-end reported balance |
$13.13B |
$12.37B |
| Shareholders’ equity |
Year-end reported balance |
$6.76B |
$6.39B |
| Net margin |
Net income ÷ revenue |
11.78% |
15.02% |
| Asset turnover |
Revenue ÷ total assets |
0.5735x |
0.6034x |
| Equity multiplier |
Total assets ÷ shareholders’ equity |
1.9413x |
1.9367x |
| ROE |
Net margin × asset turnover × equity multiplier |
13.11% |
17.55% |
Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$7.53B |
| Prior annual revenue |
$7.46B |
| EBIT |
$1.23B |
| Tax rate |
24.80% |
| NOPAT = EBIT × (1 − tax rate) |
$927.22M |
| Forecast start-growth basis |
0.91% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$927.22M |
| Add: depreciation & amortisation |
$323.00M |
| Less: capital expenditure |
-$230.00M |
| Less/(add): working-capital cash-flow movement |
$687.00M |
| Current unlevered FCFF |
$1.71B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
0.91% |
$935.66M |
$325.94M |
-$232.10M |
$693.26M |
$1.72B |
$1.66B |
| 2 |
1.31% |
$947.91M |
$330.21M |
-$258.90M |
$702.33M |
$1.72B |
$1.53B |
| 3 |
1.71% |
$964.07M |
$335.84M |
-$287.49M |
$714.31M |
$1.73B |
$1.42B |
| 4 |
2.10% |
$984.35M |
$342.90M |
-$318.22M |
$729.33M |
$1.74B |
$1.32B |
| 5 |
2.50% |
$1.01B |
$351.47M |
-$351.47M |
$747.56M |
$1.76B |
$1.24B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.64 |
| Cost of equity |
8.24% |
| Pre-tax cost of debt |
3.03% |
| WACC |
8.07% |
| WACC validation |
within standard range |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$32.30B |
| Implied terminal EV / EBITDA |
19.08x |
| Terminal value as % of enterprise value |
75.33% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$7.17B |
| Present value of terminal value |
$21.91B |
| Indicated enterprise value |
$29.09B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$29.09B |
| Less: gross interest-bearing debt |
$1.55B |
| Add: cash and equivalents |
$2.98B |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$0.00 |
| Indicated common equity value |
$30.52B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
253,000,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$209.70 |
| DCF indicative value per share |
$120.62 |
| Indicative value vs. market price |
-42.48% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
pass |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
4/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |
Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:31:06.225787 UTC; latest reported fiscal period: 2026-03-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.
2.7 Quantitative Factor Diagnostics
Factor-model exception: No sufficiently aligned issuer-return and regional factor-return sample is available. No Fama–French loading or alpha estimate is published on an incomplete basis.
Factor models are descriptive in-sample exposure diagnostics, not forecasts, investment recommendations, or estimates of future returns. This is research and analysis only, not personalized financial advice.